Sinaga AH, Zebua M, Berlian G, Aripin A. Pharmacoeconomic Evaluation and Clinical Outcomes of Channa as an Adjuvant to 20% Human Albumin Therapy in Patients with Chronic Kidney Disease: A Cost-Effectiveness Analysis (CEA) at Imelda Pekerja Indonesia General Hospital. JU-TI [Internet]. 2026 Aug. 14 [cited 2026 Aug. 29];5(01):178-87. Available from: https://jurnal.seaninstitute.or.id/index.php/juti/article/view/1151